1
|
Bal G, Kovalchuk N, Schmall J, Voronenko Y, Bailey T, Xu S, Shi L, Groll A, Sharma S, Ramos K, Shao L, Narayanan M, Kuduvalli G, Han B, Surucu M. Intrafraction Dosimetric Evaluation of Biology-Guided Radiotherapy to a Target Under Respiratory Motion. Int J Radiat Oncol Biol Phys 2023; 117:e680-e681. [PMID: 37786004 DOI: 10.1016/j.ijrobp.2023.06.2141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) To evaluate the reproducibility and variability of biology-guided radiotherapy (BgRT) treatments using a large anthropomorphic phantom modeling the motion amplitude of a lung tumor. MATERIALS/METHODS RefleXion X1 is equipped with two opposing 90 degrees PET detector arcs to capture the radionuclide emissions and direct the 6MV Linac to treat the lesions in real time. A custom-built phantom filled with a liquid [¹⁸F]Fluorodeoxyglucose (FDG) solution was used. Fillable target and OAR structures were 3D printed and attached to motion stages. The GTV = CTV was matched to the spherical 22 mm diameter target, and the PTV was a 5 mm expansion from the CTV volume. The Biology Tracking Zone (BTZ) was generated after adding 5 mm margin to the motion extent of the CTV. The OAR was a large C-shape annulus (emulating a heart) that was approximately 3 cm from the target. The 3D independent motion trajectory of the target was designed to mimic lung motion: range of +5.8 mm to -4.9 mm in LR, range of +14.4 mm to -11.3 mm in SI, and range of +5.2 mm to -5.1 mm in AP directions. The OAR motion waveform used a 1D sinusoidal pattern with a 5 mm amplitude in SI direction. The target and the OAR were filled with 40 kBq/mL while the background had 5 kBq/mL FDG. A BgRT Modeling (imaging-only) PET acquisition was performed using RefleXion X1 and used to generate a 4-fraction BgRT treatment plan prescribing 10 Gy/fraction to PTV. For each delivery, target, OAR and background were filled with the same FDG concentrations as in the BgRT Modeling PET planning scan. Dosimetry to the target and OAR were both measured using an ion-chamber (Exradin A14SL) and film in the coronal plane through the center of the GTV for all 4 fractions. RESULTS The mean activity concentration within the (BTZ) was 7.4 ± 0.8 kBq/mL. The calculated signal-to-noise ratio metric (Normalized Target Signal) within the BTZ was 4.0 ± 0.3. Total treatment times were all less than 35 minutes (34.3 ± 0.2). Prescription dose coverage to the CTV for all 4 fractions was 100%. Ion chamber measurements in the CTV were -1.6 ± 1.3% relative to the planned dose over the active area of the ion-chamber. Minimum and maximum doses to the CTV, measured on film, were -7.7 ± 2.2% and 1.3 ± 1.4%, calculated relative to the planned dose distribution, respectively. The OAR maximum point dose measured on film was -8.7 ± 2.9%, calculated relative to the maximum OAR dose predicted on the bounded dose-volume histogram. CONCLUSION Based on this initial study, accurate and reproducible dosimetry can be achieved for targets under respiratory motion using biology-guided radiotherapy over the course of a complete course of treatment. Further studies are needed to evaluate the intrafraction dosimetry of BgRT delivery under various motion models and tumor sizes.
Collapse
Affiliation(s)
- G Bal
- RefleXion Medical, Inc., Hayward, CA
| | - N Kovalchuk
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| | - J Schmall
- RefleXion Medical, Inc., Hayward, CA
| | | | - T Bailey
- RefleXion Medical, Inc., Hayward, CA
| | - S Xu
- RefleXion Medical, Inc., Hayward, CA
| | - L Shi
- RefleXion Medical, Inc., Hayward, CA
| | - A Groll
- RefleXion Medical, Inc., Hayward, CA
| | - S Sharma
- RefleXion Medical, Inc., Hayward, CA
| | - K Ramos
- RefleXion Medical, Inc., Hayward, CA
| | - L Shao
- RefleXion Medical, Inc., Hayward, CA
| | | | | | - B Han
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| | - M Surucu
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| |
Collapse
|
2
|
Groll A, Bal G, Ramos K, Sharma S, Schmall J, Narayanan M, Kuduvalli G. Decay Series Dose Delivery Validation of a Biology-Guided Radiotherapy (BgRT) Methodology. Int J Radiat Oncol Biol Phys 2023; 117:e666. [PMID: 37785969 DOI: 10.1016/j.ijrobp.2023.06.2107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) In this work, we compared the accuracy between the planned dose estimated by a commercial BgRT treatment planning system to the measured delivered dose by the BgRT treatment delivery device. The dose delivered was measured with the Sun Nuclear ArcCHECK device containing a customized phantom filled with fluorodeoxyglucose F18 (FDG) with a fixed target to background activity concentration ratio. The BgRT approach was evaluated for its capacity to accurately deliver a planned dose to a phantom target of an increasingly limited PET signal due to radioactive decay. MATERIALS/METHODS The Sun Nuclear ArcCHECK is a helical detector assembly of 1,386 diodes around a 15 cm diameter cavity designed for quality assurance of linear accelerator (LINAC) driven therapies. In this work, the ArcCHECK was loaded with a cylindrical phantom containing a 22 mm diameter homogenous ball and a C-shape insert. The ball target was designated as an organ at risk (OAR) with appropriate dose constraints applied, and the C-shaped insert was designated as the target. The C-shaped target was used to simulate a tumor with a necrotic core. A cylindrical planning/gross tumor volume was placed around the C-shape, providing a test case of delivery to a partially PET-avid target. The target and OAR were filled with 58.46 kBq/mL of FDG and the background with 7.30 kBq/mL, giving an approximate target to background ratio of 8:1. A kVCT localization scan, a short PET pre-treatment scan, and a LINAC treatment sequence (1000 cGy per fraction) were performed each run with four runs performed over a duration of ∼3.5 hours (1.9 half-lives). The ArcCHECK measured the delivered dose during each LINAC treatment sequence and compared it to the plan predicted dose. The relative dose (RD) and absolute dose (AD) gamma values were then calculated for each run using Sun Nuclear's proprietary software with a gamma pass rate criterion of 3mm/3%. RESULTS The PET scans for runs 1-4 were completed with background activity concentrations of 5.49 kBq/ml, 3.95 kBq/ml, 2.79 kBq/ml, and 2.02 kBq/ml, respectively. The scans further reported 17.48 kBq/ml, 12.26 kBq/ml, 7.93 kBq/ml, and 6.95 kBq/ml as the mean activity concentrations for the cylindrical gross tumor volume of the planned treatment. After treatment delivery, the resulting RD gamma values were 98%, 94%, 93%, and 95% and AD gamma values were 98%, 93%, 92%, and 94% for runs 1-4. CONCLUSION Results from this study demonstrated treatment delivery stability with consistent repeatability in the 8:1 target to background contrast condition even with diminishing PET signal from the phantom target as the activity decayed. This work shows that BgRT is capable of delivering to a cylindrical target volume that is very different from the PET avid C-shaped that was used for the plan and delivery.
Collapse
Affiliation(s)
- A Groll
- RefleXion Medical, Inc., Hayward, CA
| | - G Bal
- RefleXion Medical, Inc., Hayward, CA
| | - K Ramos
- RefleXion Medical, Inc., Hayward, CA
| | - S Sharma
- RefleXion Medical, Inc., Hayward, CA
| | - J Schmall
- RefleXion Medical, Inc., Hayward, CA
| | | | | |
Collapse
|
3
|
Schmall J, Bal G, Khan S, Xu S, Voronenko Y, Shi L, Mitra A, Groll A, Sharma S, Ramos K, Shao L, Narayanan M, Olcott P, Kuduvalli G, Han B, Kovalchuk N, Surucu M. Dosimetric Accuracy of Multi-Target Biology-Guided Radiotherapy Treatments in a Single Session. Int J Radiat Oncol Biol Phys 2023; 117:e722. [PMID: 37786108 DOI: 10.1016/j.ijrobp.2023.06.2232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) We present the first dosimetric measurements of single session, multi-target BgRT deliveries using a clinically realistic motion phantom on a research-only version of the RefleXion X1 system. MATERIALS/METHODS A custom-made anthropomorphic phantom of a human torso with embedded fillable targets mimicking 18F-FDG-avid lesions was used. From the three embedded spherical targets, Target 1 was 26 mm in diameter coupled with a 3D independent respiratory motion with 22 mm range, whereas Target 2 and 3 were 22 mm in diameter and moved with a 1D 5 mm maximum sinusoidal motion. The 18F-FDG concentration in the background cavity of the phantom was 5 kBq/ml, and the targets were loaded with 10:1, 8:1 and 6:1 contrast relative to the background for Targets 1, 2, 3, respectively. Spherical structures were contoured as GTVs (CTV = GTV) and a 5 mm margin was added to create PTVs. Motion extent of the tumors were captured to create biological tracking zones for each target. Treatment plans were generated using a research version of the Reflexion treatment planning software to deliver 8 Gy/fx to the PTVs. The treatment delivery was repeated 2 times, and each time the phantom was refilled according to the plan. PET image evaluation metrics for each of the three targets were also recorded. Target dosimetry was measured using a combination of radiographic film and ion chamber. The maximum distance between the 97% prescription isodose line from the plan and the film measurements was used to characterize the dosimetric accuracy of the tracked deliveries. CTV and PTV min, max, and mean doses measured on film were also recorded for each target. RESULTS Treatment plans were successfully created with 100% prescription dose coverage to each target loaded with different FDG ratios. Total treatment times for the single-plan, three-target deliveries were less than 80 minutes. PET evaluation metrics at imaging-only and pre-scan, and planning and film dosimetry to the GTV and PTV for each of the three targets is shown in table below (mean ± standard deviation of both deliveries). The CTV dose coverage was maintained for all targets. The shrinkage distance of the 97% prescription dose isodose line on the film plane for all three targets was less than 3 mm for both tests, and ranged from -0.4 to -2.34 mm. CONCLUSION These results demonstrate that high tracking accuracy and dosimetric accuracy can be achieved in single session, multi-target deliveries over a range of target-to-background 18F-FDG concentrations and target motion patterns.
Collapse
Affiliation(s)
- J Schmall
- RefleXion Medical, Inc., Hayward, CA
| | - G Bal
- RefleXion Medical, Inc., Hayward, CA
| | - S Khan
- RefleXion Medical, Inc., Hayward, CA
| | - S Xu
- RefleXion Medical, Inc., Hayward, CA
| | | | - L Shi
- RefleXion Medical, Inc., Hayward, CA
| | - A Mitra
- RefleXion Medical, Inc., Hayward, CA
| | - A Groll
- RefleXion Medical, Inc., Hayward, CA
| | - S Sharma
- RefleXion Medical, Inc., Hayward, CA
| | - K Ramos
- RefleXion Medical, Inc., Hayward, CA
| | - L Shao
- RefleXion Medical, Inc., Hayward, CA
| | | | - P Olcott
- RefleXion Medical, Inc., Hayward, CA
| | | | - B Han
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| | - N Kovalchuk
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| | - M Surucu
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| |
Collapse
|
4
|
Mitra A, Bal G, Xu S, Voronenko Y, Schmall J, Narayanan M, Shao L, Kuduvalli G. Treatment Plan Creation and Delivery with and without BgRT for Static and Motion Trajectories. Int J Radiat Oncol Biol Phys 2023; 117:e697-e698. [PMID: 37786043 DOI: 10.1016/j.ijrobp.2023.06.2179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) In this work we try to validate the motion tracking capabilities of BgRT for periodic and step motion trajectories. SBRT plans that matches the corresponding BgRT plans are created and delivered to the same phantom with and without motion and results are evaluated. Using BgRT based SBRT plans eliminates any user bias and creates SBRT plans that would represent treatment delivery scenarios that could have happened if the PET guided BgRT was not present for that treatment. MATERIALS/METHODS To validate SBRT plans that matches the BgRT plans, we used three different types of motion patterns (1) static, (2) lung tumor motion and (3) one-centimeter step-shift. The lung tumor motion (∼25 mm in IEC-Y, ∼7 mm in IEC-X and ∼ 10 mm in IEC-Z) was used as it represents a continuous motion of the target for the entire length of the study while the step-shift case corresponds to the patient or tumor shifting between the localization CT and the start of treatment. First, a 10 Gy per fraction BgRT plan was created for each of the three experiments based on the corresponding PET image. Then, the BgRT plans were delivered to the corresponding targets with and without motion and results are evaluated. To perform a comparative study that assess the performance of BgRT and traditional SBRT (planning and delivery methods), the exact same plan fluence of BgRT plan for each experiment was used to create the corresponding SBRT plans. The newly created SBRT plans were delivered to the corresponding phantom experiments and were compared against BgRT delivery in terms of dose coverage and target margin loss using radiochromic film that moves with the target. The margin loss was calculated as the difference between the distance from the CTV contour to the 97% isodose contour in the treatment plan and the CTV contour to the 97% isodose contour on the film. Dosimetric coverage was on the other hand calculated as the percentage of the voxels within the CTV that lies within 97% and 130% of the prescribed dose. RESULTS The results showed that the margin loss for BgRT is less than 3 mm, while for the SBRT plans were more than 3 mm when target motion is present. The dosimetric coverage for BgRT was 100% for all three cases, however less than 100% for the SBRT cases with motion. Table showing margin loss for the various experiments for a prescription dose of 10 Gy. CONCLUSION The results shows that BgRT is capable of tracking the tumor motion and delivering the prescribed dose to the moving target.
Collapse
Affiliation(s)
- A Mitra
- RefleXion Medical, Inc., Hayward, CA
| | - G Bal
- RefleXion Medical, Inc., Hayward, CA
| | - S Xu
- RefleXion Medical, Inc., Hayward, CA
| | | | - J Schmall
- RefleXion Medical, Inc., Hayward, CA
| | | | - L Shao
- RefleXion Medical, Inc., Hayward, CA
| | | |
Collapse
|
5
|
Han B, Schmall J, Bal G, Khan S, Voronenko Y, Xu S, Shi L, Mitra A, Groll A, Sharma S, Ramos K, Shao L, Narayanan M, Olcott P, Kuduvalli G, Kovalchuk N, Surucu M. Characterization of Biology-Guided Radiotherapy Accuracy as a Function of PET Tracer Uptake. Int J Radiat Oncol Biol Phys 2023; 117:e668-e669. [PMID: 37785972 DOI: 10.1016/j.ijrobp.2023.06.2113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) To characterize the tracking capability and dosimetric accuracy of biology-guided radiotherapy (BgRT) under clinically relevant PET tracer uptake scenarios relative to the background. MATERIALS/METHODS A custom-made anthropomorphic phantom filled with a liquid 18F-FDG solution including two embedded fillable 22 mm diameter spherical structures mimicking GTV (= CTV) and OAR was coupled to motion stages to create an independent 3D respiratory motion with 22 mm maximum range for target and a 5 mm 1D sinusoidal motion in the OAR. The biology-tracking zone (BTZ) was generated by adding 5 mm margin to the motion extent. The three BgRT scenarios studied were representative of tumors with good (8:1), borderline (4:1) and undesired (2:1) PET biodistributions compared to background. The clinical safety limit of BgRT uses Activity Concentration within the BTZ (AC ≥ 5 kBq/ml) and Normalized Target Signal as a contrast metric (NTS ≧ 2.7 for planning and ≧ 2 for delivery). The BgRT deliveries were repeated 3 times with radiochromic film and integrated ion chamber capturing the target and OAR doses. Tracked dosimetry was assessed using a margin-loss calculation defined as the maximum linear difference in distance between the planned and delivered 97% prescription iso-dose lines. RESULTS The imaging-only PET images used to create BgRT plans had an AC of 7.0, 5.3, and 1.6 kBq/ml with an NTS of 6.8, 5.3, and 1.8 for 8:1, 4:1, and 2:1 concentrations, respectively. Qualitatively, the target was not visible on the planning PET images 2:1 loading scenario. At delivery, the mean pre-scan activity concentrations were 6.8, 4.7, and 3.7 kBq/ml with corresponding mean NTS of 3.7, 2.6, 1.5 for 8:1, 4:1 and 2:1 deliveries. The pre-scan values of AC or NTS did not satisfy the clinical system safety limits for 4:1 and 2:1 ratio experiments, but the engineering software allowed for the delivery to capture the resulting doses. The deliveries showed a prescription dose coverage to the CTV of 100% for the 8:1 and 4:1 cases, but 88% for the 2:1 case. When compared to the planned dose values, the delivered minimum doses were -7.6%, -8.6% and -10.9%, whereas the maximum dose differences in CTV were 1.2%, 0% and -4.8% of the planned dose distributions of the 8:1, 4:1 and 2:1 cases, respectively. Calculated margin losses were -2.3, -3.8, and -5.5 mm, for the 8:1, 4:1, and 2:1 cases, respectively. The maximum OAR doses were less than the maximum doses predicted on the bounded DVH curves for all scenarios. CONCLUSION With sufficient tracer uptake in the target, BgRT can deliver tracked dosimetry for targets with a large respiratory motion profile. Both the good BgRT candidate and borderline cases produced clinically acceptable delivered doses, even though the borderline case was flagged by the clinical system safety checks. As expected, the delivered BgRT dose distributions were suboptimal with reduced tumor over background PET contrast.
Collapse
Affiliation(s)
- B Han
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| | - J Schmall
- RefleXion Medical, Inc., Hayward, CA
| | - G Bal
- RefleXion Medical, Inc., Hayward, CA
| | - S Khan
- RefleXion Medical, Inc., Hayward, CA
| | | | - S Xu
- RefleXion Medical, Inc., Hayward, CA
| | - L Shi
- RefleXion Medical, Inc., Hayward, CA
| | - A Mitra
- RefleXion Medical, Inc., Hayward, CA
| | - A Groll
- RefleXion Medical, Inc., Hayward, CA
| | - S Sharma
- RefleXion Medical, Inc., Hayward, CA
| | - K Ramos
- RefleXion Medical, Inc., Hayward, CA
| | - L Shao
- RefleXion Medical, Inc., Hayward, CA
| | | | - P Olcott
- RefleXion Medical, Inc., Hayward, CA
| | | | - N Kovalchuk
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| | - M Surucu
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
| |
Collapse
|
6
|
Khan S, Narayanan M, Olcott P, Oderinde O, Bal G, Schmall J, Xu S, Voronenko Y, Shao L, Kuduvalli G, Surucu M. Robustness of Biology-Guided Radiotherapy Delivery to PET Biodistribution Changes within Target. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.2180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
7
|
Dokhale P, Schmall J, Stapels C, Christian J, Cherry S, Squillante MR, Shah K. Imaging and Timing Performance of 1cm × 1cm Position-sensitive Solid-state Photomultiplier. J Instrum 2013; 8:C02033. [PMID: 25540669 PMCID: PMC4273939 DOI: 10.1088/1748-0221/8/02/c02033] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
We have designed and built a large-area 1cm × 1cm position-sensitive solid-state photomultiplier (PS-SSPM) for use in detector design for medical imaging applications. Our new large-area PS-SSPM concept implements resistive network between the micro-pixels, which are photodiodes operated in Geiger mode, called Geiger Photodiodes (GPDs), to provide continuous position sensitivity. Here we present imaging and timing performance of the large-area PS-SSPM for different temperatures and operating biases to find the optimum operating parameters for the device in imaging applications. A detector module was built by coupling a polished 8×8 LYSO array, with 1×1×20 mm3 elements, to a 1×1 cm2 PS-SSPM. Flood images recorded at room temperature show good crystal separation as all 64 elements were separated from each other. Cooling the device at 10 °C showed significant improvement. The device optimum bias voltage was ~4.5V over breakdown voltage. The coincidence timing resolution was improved significantly by increasing the operating bias, as well as by lowering the temperature to 0 °C. Results show excellent imaging performance and good timing response with a large-area PS-SSPM device.
Collapse
Affiliation(s)
- P. Dokhale
- Radiation Monitoring Devices, Inc. 44 Hunt Street, Watertown, MA 02472, USA
| | - J. Schmall
- Department of Biomedical Engineering, University of California-Davis, Davis, CA 95616, USA
| | - C. Stapels
- Radiation Monitoring Devices, Inc. 44 Hunt Street, Watertown, MA 02472, USA
| | - J. Christian
- Radiation Monitoring Devices, Inc. 44 Hunt Street, Watertown, MA 02472, USA
| | - S. Cherry
- Department of Biomedical Engineering, University of California-Davis, Davis, CA 95616, USA
| | - M. R. Squillante
- Radiation Monitoring Devices, Inc. 44 Hunt Street, Watertown, MA 02472, USA
| | - K. Shah
- Radiation Monitoring Devices, Inc. 44 Hunt Street, Watertown, MA 02472, USA
| |
Collapse
|